{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Arendt BK"],"funding":["NCI NIH HHS","NIGMS NIH HHS"],"pagination":["1931-41"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC2518895"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["112(5)"],"pubmed_abstract":["Primary systemic amyloidosis (AL) is a rare monoclonal plasma cell (PC) disorder characterized by the deposition of misfolded immunoglobulin (Ig) light chains (LC) in vital organs throughout the body. To our knowledge, no cell lines have ever been established from AL patients. Here we describe the establishment of the ALMC-1 and ALMC-2 cell lines from an AL patient. Both cell lines exhibit a PC phenotype and display cytokine-dependent growth. Using a comprehensive genetic approach, we established the genetic relationship between the cell lines and the primary patient cells, and we were also able to identify new genetic changes accompanying tumor progression that may explain the natural history of this patient's disease. Importantly, we demonstrate that free lambda LC secreted by both cell "],"journal":["Blood"],"pubmed_title":["Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2."],"pmcid":["PMC2518895"],"funding_grant_id":["CA062242","GM071514","R01 GM071514","P01 CA062242"],"pubmed_authors":["Sikkink LA","Ahmann GJ","Zeldenrust SR","Fonseca R","Dispenzieri A","Keats JJ","Ramirez-Alvarado M","Ketterling RP","Arendt BK","Jelinek DF","Tschumper RC","Knudson RA","Mulvihill EM","Wu X"],"additional_accession":[]},"is_claimable":false,"name":"Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2.","description":"Primary systemic amyloidosis (AL) is a rare monoclonal plasma cell (PC) disorder characterized by the deposition of misfolded immunoglobulin (Ig) light chains (LC) in vital organs throughout the body. To our knowledge, no cell lines have ever been established from AL patients. Here we describe the establishment of the ALMC-1 and ALMC-2 cell lines from an AL patient. Both cell lines exhibit a PC phenotype and display cytokine-dependent growth. Using a comprehensive genetic approach, we established the genetic relationship between the cell lines and the primary patient cells, and we were also able to identify new genetic changes accompanying tumor progression that may explain the natural history of this patient's disease. Importantly, we demonstrate that free lambda LC secreted by both cell ","dates":{"release":"2008-01-01T00:00:00Z","publication":"2008 Sep","modification":"2025-04-04T21:05:51.699Z","creation":"2019-03-27T00:16:16Z"},"accession":"S-EPMC2518895","cross_references":{"pubmed":["18567838"],"doi":["10.1182/blood-2008-03-143040"]}}